HARVARD MANAGEMENT CO INC - Q4 2020 holdings

$1.84 Billion is the total value of HARVARD MANAGEMENT CO INC's 30 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 58.3% .

 Value Shares↓ Weighting
RPRX  ROYALTY PHARMA PLC$735,274,000
+19.0%
14,690,7800.0%39.88%
+17.3%
CRM NewSALESFORCE COM INC$206,406,000927,541
+100.0%
11.20%
MSFT NewMICROSOFT CORP$182,621,000821,062
+100.0%
9.90%
ABCL NewABCELLERA BIOLOGICS INC$165,189,0004,105,095
+100.0%
8.96%
SGMS  SCIENTIFIC GAMES CORP$111,134,000
+18.8%
2,678,5710.0%6.03%
+17.2%
FB SellFACEBOOK INCcl a$111,050,000
-61.0%
406,540
-62.6%
6.02%
-61.5%
PANW SellPALO ALTO NETWORKS INC$59,422,000
-66.6%
167,202
-77.0%
3.22%
-67.0%
PRAX NewPRAXIS PRECISION MEDICINES I$43,610,000792,617
+100.0%
2.36%
QQQ SellINVESCO QQQ TRunit ser 1$35,379,000
+12.4%
112,765
-0.4%
1.92%
+10.9%
RVMD  REVOLUTION MEDICINES INC$26,540,000
+13.8%
670,3820.0%1.44%
+12.2%
IVV  ISHARES TRcore s&p500 etf$24,277,000
+11.7%
64,6720.0%1.32%
+10.2%
RLAY  RELAY THERAPEUTICS INC$22,489,000
-2.4%
541,1240.0%1.22%
-3.7%
KNTE NewKINNATE BIOPHARMA ORD$19,810,000498,001
+100.0%
1.07%
GLD SellSPDR GOLD TR$17,233,000
-18.2%
96,619
-18.8%
0.94%
-19.3%
GBIO BuyGENERATION BIO CO$14,783,000
-5.5%
521,460
+3.0%
0.80%
-6.9%
PLRX  PLIANT THERAPEUTICS INC$12,777,000
+0.3%
562,3790.0%0.69%
-1.0%
NRIX  NURIX THERAPEUTICS INC$10,349,000
-5.8%
314,7620.0%0.56%
-7.1%
VEA  VANGUARD TAX-MANAGED INTL FDftse dev mkt etf$8,216,000
+15.4%
174,0410.0%0.45%
+14.1%
NCNA SellNUCANA PLCsponsored adr$7,535,000
-37.5%
1,678,239
-27.7%
0.41%
-38.3%
FULC  FULCRUM THERAPEUTICS INC$4,809,000
+47.7%
410,7140.0%0.26%
+45.8%
IJR  ISHARES TRcore s&p scp etf$4,568,000
+30.9%
49,7100.0%0.25%
+29.2%
VWO  VANGUARD INTL EQUITY INDEX Fftse emr mkt etf$4,027,000
+15.9%
80,3600.0%0.22%
+14.1%
IJH SellISHARES TRcore s&p mcp etf$3,736,000
+8.7%
16,255
-12.3%
0.20%
+7.4%
MCRB NewSERES THERAPEUTICS INC$3,230,000131,847
+100.0%
0.18%
FSDC NewFS DEV CORP$2,750,000250,000
+100.0%
0.15%
MGTA  MAGENTA THERAPEUTICS INC$2,608,000
+15.3%
332,6100.0%0.14%
+13.7%
DYN  DYNE THERAPEUTICS INC$2,252,000
+4.0%
107,2520.0%0.12%
+2.5%
CG NewCARLYLE GROUP INC$742,00023,600
+100.0%
0.04%
TWLO NewTWILIO INCcl a$684,0002,021
+100.0%
0.04%
PGNY NewPROGYNY INC$159,0003,755
+100.0%
0.01%
ASAN ExitASANA INCcl a$0-75,946
-100.0%
-0.12%
UBER ExitUBER TECHNOLOGIES INC$0-2,720,937
-100.0%
-5.46%
ICE ExitINTERCONTINENTAL EXCHANGE IN$0-1,161,137
-100.0%
-6.39%
GOOGL ExitALPHABET INCcap stk cl a$0-156,543
-100.0%
-12.62%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1843661000.0 != 1843659000.0)

Export HARVARD MANAGEMENT CO INC's holdings